https://www.selleckchem.com/pr....oducts/mivebresib-ab
Proponents of personalized medicine have promoted neuroimaging in three areas of clinical application for major depression clinical prediction, outcome evaluation, and treatment, via neurofeedback. Whereas psychometric considerations such as test-retest reliability are basic precursors to clinical adoption for most clinical instruments, we show, in this article, that basic psychometrics have not been regularly attended to in fMRI of depression. For instance, no fMRI neurofeedback study has included measures of test-retest re
Like
Comment
Share
